Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates

OtherBRAIN

Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings

Antônio J. da Rocha, Flávio T. Braga, Carlos J. da Silva, Antônio C. M. Maia, Guilherme S. Mourão and Rubens J. Gagliardi
American Journal of Neuroradiology August 2004, 25 (7) 1247-1250;
Antônio J. da Rocha
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Flávio T. Braga
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos J. da Silva
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Antônio C. M. Maia Jr
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guilherme S. Mourão
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rubens J. Gagliardi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

Summary: Parkinsonism and portosystemic encephalopathy (PSE) are cerebral disorders associated with motor and neuropsychological dysfunctions that may occur in patients with chronic liver disease. We describe a patient with parkinsonism and neuroradiologic and 1H spectroscopic findings of PSE associated with a large congenital intrahepatic portosystemic venous shunt. Chronic liver disease was absent. After endovascular treatment, we documented a progressive reversal of parkinsonism and PSE on the basis of clinical, neuroradiologic, and spectroscopic criteria.

Parkinsonism and portosystemic encephalopathy (PSE) are reversible cerebral disorders associated with motor and neuropsychological dysfunctions that may develop in patients with portosystemic shunts secondary to chronic liver disease, surgery, or rarely, an isolated congenital intra- or extrahepatic portosystemic venous shunt (1–4). PSE patients may present symptoms of parkinsonism and show characteristic brain MR imaging and 1H spectroscopic findings, despite the cause of the shunt (2, 5–10). We describe a progressive reversal of parkinsonism and PSE following embolization of a congenital intrahepatic portosystemic venous shunt, with emphasis on brain MR imaging and 1H spectroscopic findings.

Case Report

A 48-year-old woman presented with a history of parkinsonism defined by the presence of progressive bradykinesia and rigidity over a 24-month period. There were no signs of PSE on clinical examination. Subclinical PSE was diagnosed on the basis of neuropsychological impairments by using the Wechsler Adult Intelligence Scale—Revised, subtests Block Design and Digit Symbol from the Wechsler Adult Intelligence Scale Manual. Laboratory studies at the time of our examination showed normal electrolytes. The hematocrit, white blood cell count, platelets, prothrombin time, bilirubins, albumin, alanine aminotrasferase, aspartate aminotransferase, and gamma-glutamyltransferase levels revealed no abnormalities. The electroencephalographic findings were unremarkable.

MR imaging and 1H MR spectroscopy were performed at 1.5 T. T1-weighted (TR = 400 ms; TE = 20 ms) images showed typical neuroradiologic findings of PSE characterized by bilateral and symmetrical hyperintensities in the substantia nigra, cerebral peduncle, subthalamic region, hemispheric white matter, globus pallidus, and putamen (Fig 1A–C).

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

Initial examination. T1-weighted MR images show bilateral and symmetrical hyperintensities in the substantia nigra and cerebral peduncle (A), subthalamic region and hemispheric white matter (B), and the globus pallidus and putamen (C).

The diagnosis of PSE was also based on 1H spectroscopic findings by using a stimulated-echo acquisition mode technique (TR = 1,500 ms; TE = 30 ms) with the volume of interest placed in the medial part of the occipital lobes. We decided to place the volume of interest in the medial part of the occipital lobes because this area contains gray and white matter and allows measurement of a volume of interest with good homogeneity of the magnetic field, as proposed by Ross et al (8). In addition, it has been shown that occipital gray and white matter exhibit essentially identical MR spectroscopic metabolite changes in PSE when compared with parietal white matter regions (8).

For the major resonances—n-acetylaspartate (NAA), choline (Cho), and myo-inositol (mI)—ratios of metabolites were obtained, with creatine (Cr) used as a reference. Because of the considerable overlap between glutamate and glutamine (the metabolite of interest in this article), two integrations of peak areas were obtained for each spectrum, from the coupled peaks defining beta, gamma-glutamine between 2.2 and 2.4 ppm and alpha-glutamine between 3.6 and 3.75 ppm as proposed by Ross et al (8). These integrals were referred to as Glx. To define PSE at 1H spectroscopy, quantitative criteria were selected on the basis of demonstrated normal ranges for mI/Cr and Cho/Cr and the magnitude of changes from these mean values observed in an earlier study (8): mI/Cr and Cho/Cr <2 SD below normal.

According to previously published parameters (8)—with normal ratios indicated in parenthesis—the pretreatment analysis showed decreased mI/Cr = 0.43 (0.51–0.63) and Cho/Cr = 0.43 (0.50–0.68) ratios (Fig 2).

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

Initial examination. 1H spectroscopy shows decreased mI/Cr and Cho/Cr ratios and an elevated alpha- and beta-, gamma-Glx/Cr peak areas ratios (arrows).

In the absence of hepatic failure, screening for a possible congenital shunt was performed and included an abdominal MR angiography examination. We detected a large congenital intrahepatic portosystemic venous shunt that communicated with the posterior division of the right branch of portal vein to the right hepatic vein, with an associated aneurysm (Fig 3A). It was further studied by digital angiography (Fig 3B). A percutaneous transhepatic sonographically guided catheterization of the left branch of portal vein was performed. The endovascular catheter was repositioned at the posterior division of the right branch of portal vein, and the portosystemic venous shunt and associated aneurysm were successfully occluded with the injection of n-butyl cyanoacrylate (Fig 3C).

Fig 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 3.

Angio-MR examination (A) shows the right branch of portal vein (arrow), the intrahepatic aneurysm (arrowhead), and the right hepatic vein (smaller arrow). Portogram (B) shows the aneurysm (arrow) at the posterior division of the right branch of portal vein. Portogram after embolization (C) shows successful occlusion of the shunt and associated aneurysm.

Progressive recovery of the parkinsonism was observed after treatment. MR imaging and 1H spectroscopy were performed 6 (Fig 4A and B) and 9 (Fig 4C and D) months later. After 6 months, the spectroscopic analysis already showed normalization of the mI/Cr and Cho/Cr ratios (mI/Cr = 0.61, Cho/Cr = 0.56; Fig 4B). Because of the relatively large standard deviations associated with determination of peak area ratios for glutamine, it is difficult to draw conclusions on the basis of one pretreatment spectrum and two post-treatment (6- and 9-month) spectra. These three consecutive spectra, however, showed a progressive decrease of the alpha- and beta, gamma-Glx/Cr peak areas ratios, as follows: alpha-Glx/Cr = 0.54, 0.48, and 0.30; beta, gamma-Glx/Cr = 0.79, 0.68, and 0.60 (Figs 2; 4B and D), respectively. In addition, the NAA/Cr ratios showed almost no variation, as follows: NAA/Cr = 1.42, 1.41, and 1.43, respectively.

Fig 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 4.

Follow-up examinations after 6 (A, B) and 9 (C, D) months. T1-weighted MR images on the left show a progressive decrease of the symmetrical bilateral high signal intensity in the globus pallidus and putamen, and 1H spectroscopic measurements on the right show normalization of the mI/Cr and Cho/Cr ratios and a progressive decrease of the alpha- and beta, gamma-Glx/Cr peak areas ratios after 6 and 9 months (arrows).

The signal intensity abnormalities observed on T1-weighted images turned progressively into normal findings in a 9-month period (Fig 4A and C).

Discussion

We report the case of a patient with chronic and progressive symptoms of parkinsonism and neuroradiologic and 1H spectroscopic findings of PSE associated with a congenital intrahepatic portosystemic venous shunt, in the absence of any liver function abnormality. PSE is a distinct entity among parkinsonian syndromes (10), and neuropsychological tests showed subclinical disease in our patient. She presented with a progressive symmetrical akinetic-rigid syndrome with a notably absent resting tremor.

There was no history of alcoholism. Some features allow Parkinson disease as well as Parkinson-plus syndromes to be reasonably ruled out in this patient, such as absence of resting tremor and the relative symmetry of symptoms. Wilson disease was also ruled out. Similar parkinsonian symptoms have been described in the setting of hepatic failure and in spontaneous, surgical, or even congenital portosystemic shunt (2, 7, 11). MR imaging studies show, on T1-weighted images, bilateral and symmetrical hyperintensities in the globus pallidus, putamen, subthalamic region, substantia nigra, cerebral peduncle, and hemispheric white matter as in our report (2, 5, 7). Reasonable evidence points toward increased endogenous manganese deposition into the basal ganglia as a major cause of MR imaging hyperintensities observed in patients with portosystemic shunt (6, 7, 11). The involvement of the hemispheric white matter seems to be secondary to astrocytic edema (12).

Despite the large congenital intrahepatic portosystemic venous shunt, our patient did not present with any evidence of PSE on clinical examination. It has been shown that even in subclinical PSE, a specific pattern of cerebral metabolic changes exists in the brain, and this pattern can be noninvasively detected by using short-TE 1H spectroscopy (8). According to the literature, such striking and simultaneous changes in cerebral mI/Cr, Cho/Cr, and Glx/Cr ratios have not yet been described in association with other encephalopathies (8, 9). This high sensitivity is underscored by reports of few patients who exhibited mild 1H spectroscopic findings before developing PSE and in whom psychometric test results were notably normal (8). The markedly decreased mI signals in patients with PSE seem to reflect a disturbance of cell volume homeostasis in the brain, which may occur at preclinical stages of PSE in vivo. This disturbance of brain cell volume homeostasis may be attributed to an intracellular accumulation of glutamine in response to hyperammonemia. The 1H spectroscopic signal intensity for glutamine is increased with a compensatory loss of mI content in both preclinical and overt PSE. In light of the fact that glutamine formation from ammonia is a glial but not a neuronal process, glial cell swelling seems to be involved (12).

It has been shown that proper treatment of the underlying cause can revert the parkinsonian symptoms and the chain of metabolic abnormalities in PSE (2, 4, 9). In our report, the patient presented a striking clinical, neuroradiologic, and spectroscopic recovery over a 9-month period following endovascular therapy. It has been demonstrated that, despite the treatment of the causative factor, the reversal of both brain MR imaging and 1H spectroscopic abnormalities is slow, and the latter frequently reverses before the former (9), as in our case.

Conclusion

The congenital portosystemic venous shunt can be a potential treatable cause of acquired parkinsonism and PSE and must be suspected in every patient with brain MR imaging findings of PSE without evidence of liver failure. Brain MR imaging and 1H spectroscopy proved to be useful tools for the diagnosis and post-treatment follow-up in this situation, requiring months to demonstrate the reversibility of the process.

References

  1. ↵
    Butterworth RF. Complications of cirrhosis III: hepatic encephalopathy. J Hepatol 2000;32(suppl 1):S171–S180
  2. ↵
    Krieger S, Jauss M, Jansen O, et al. MRI findings in chronic hepatic encephalopathy depend on portosystemic shunt: results of a controlled prospective clinical investigation. J Hepatol 1997;27:121–126
    CrossRefPubMed
  3. Raskin NH, Price JB, Fishman RA. Portosystemic encephalopathy due to congenital intrahepatic shunts. N Engl J Med 1964;270:225–229
  4. ↵
    Akahoshi T, Nishizaki T, Wakasugi K, et al. Portal-systemic encephalopathy due to a congenital extrahepatic portosystemic shunt: three cases and literature review. Hepato-Gastroenterology 2000;47:1113–1116
    PubMed
  5. ↵
    Inoue E, Hori S, Narumi Y, et al. Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 1991;179:551–555
    PubMed
  6. ↵
    Maeda H, Sato M, Yoshikawa A, et al. Brain MR imaging in patients with hepatic cirrhosis: relationship between high intensity signal in basal ganglia on T1-weighted images and elemental concentrations in brain. Neuroradiology 1997;39:546–550
    CrossRefPubMed
  7. ↵
    Burkhard PR, Delavelle J, Du Pasquier R, Spahr L. Chronic parkinsonism associated with cirrhosis. Arch Neurol 2003;60:521–528
    CrossRefPubMed
  8. ↵
    Ross BD, Jacobson S, Villamil F, et al. Subclinical hepatic encephalopathy: proton MR spectroscopic abnormalities. Radiology 1994;193:457–463
    PubMed
  9. ↵
    Naegele T, Grodd W, Viebahn R, et al. MR imaging and 1H spectroscopy of brain metabolites in hepatic encephalopathy: time-course of renormalization after liver transplantation. Radiology 2000;216:683–691
    PubMed
  10. ↵
    Spahr L, Vingerhoets R, Lazeyras F, et al. Magnetic resonance imaging and proton spectroscopic alterations correlate with parkinsonian signs in patients with cirrhosis. Gastroenterology 2000;119:774–781
    CrossRefPubMed
  11. ↵
    Yoshikawa K, Matsumoto M, Hamanaka M, Nakagawa M. A case of manganese-induced parkinsonism in hereditary haemorrhagic telangiectasia. J Neurol Neurosurg Psychiatry 2003;74:1312–1314
    Abstract/FREE Full Text
  12. ↵
    Häussinger D, Laubenberger J, vom Dahl S, et al. Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypoosmolarity and hepatic encephalopathy. Gastroenterology 1994;107:1475–1480
    CrossRefPubMed
  • Received October 17, 2003.
  • Accepted after revision December 19, 2003.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 25 (7)
American Journal of Neuroradiology
Vol. 25, Issue 7
1 Aug 2004
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
Antônio J. da Rocha, Flávio T. Braga, Carlos J. da Silva, Antônio C. M. Maia, Guilherme S. Mourão, Rubens J. Gagliardi
Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings
American Journal of Neuroradiology Aug 2004, 25 (7) 1247-1250;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Reversal of Parkinsonism and Portosystemic Encephalopathy Following Embolization of a Congenital Intrahepatic Venous Shunt: Brain MR Imaging and 1H Spectroscopic Findings
Antônio J. da Rocha, Flávio T. Braga, Carlos J. da Silva, Antônio C. M. Maia, Guilherme S. Mourão, Rubens J. Gagliardi
American Journal of Neuroradiology Aug 2004, 25 (7) 1247-1250;
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Case Report
    • Discussion
    • Conclusion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • Usefulness of Quantitative Susceptibility Mapping for the Diagnosis of Parkinson Disease
  • White Matter Alterations in the Brains of Patients with Active, Remitted, and Cured Cushing Syndrome: A DTI Study
  • Qualitative and Quantitative Analysis of MR Imaging Findings in Patients with Middle Cerebral Artery Stroke Implanted with Mesenchymal Stem Cells
Show more BRAIN

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire